Authors
Nicolas Deniau, Swasti Roux, Zoé Belot, Katell Bost, Alexia Le Deuff, Yann Orven, David Renault, Jeremy Leraut, Béatrice Piot, Hamat Sall, Anthony Mezière
Published in
Geriatrie et psychologie neuropsychiatrie du vieillissement. Volume 24. Issue 2. Pages 198-206. Jun 01, 2026.
Abstract
Neurocognitive disorders represent a major public health challenge. We report the experience of a diagnostic day hospital that systematically integrates both a clinical pharmacist and a speech-language pathologist in a socioeconomically advantaged area. This retrospective study included patients undergoing their initial assessment at the day hospital. The primary objective was to describe their neurocognitive, pharmaceutical, and speech-language characteristics. As a secondary objective, we investigated differences according to educational level in pharmaceutical and speech-language assessments and recommendations. A total of 110 patients were included. Polypharmacy was identified in 55% of patients, and at least one pharmaceutical intervention was recommended in 75%. A high prevalence of language disorders was observed, leading to referral for speech therapy in 61% of cases. Compared with the general population consulting for neurocognitive disorders, our patients had a higher average sociocultural level. No significant differences according to educational level were observed in pharmaceutical or speech-language assessment outcomes. These findings highlight the potential value of integrating clinical pharmacy and speech-language pathology into multidisciplinary neurocognitive assessment pathways.
PMID:
42412504
Bibliographic data and abstract were imported from PubMed on 07 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0